B-Cell Translocation Gene 2 (Btg2) Regulates Vertebral Patterning by Modulating Bone Morphogenetic Protein/Smad Signaling
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Btg2 is a primary p53 transcriptional target gene which may function as a coactivator-corepressor and/or an adaptor molecule that modulates the activities of its interacting proteins. We have generated Btg2-null mice to elucidate the in vivo function of Btg2. Btg2-null mice are viable and fertile but exhibit posterior homeotic transformations of the axial vertebrae in a dose-dependent manner. Consistent with its role in vertebral patterning, Btg2 is expressed in the presomitic mesoderm, tail bud, and somites during somitogenesis. We further provide biochemical evidence that Btg2 interacts with bone morphogenetic protein (BMP)-activated Smads and enhances the transcriptional activity of BMP signaling. In view of the genetic evidence that reduced BMP signaling causes posteriorization of the vertebral pattern, we propose that the observed vertebral phenotype in Btg2-null mice is due to attenuated BMP signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hox10 and Hox11 Genes Are Required to Globally Pattern the Mammalian Skeleton
Wellik, D. M., & Capecchi, M. R. (2003) · Science · doi:10.1126/science.1085672 · Cited by 586
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1999) · Nature Genetics · doi:10.1038/10320 · Cited by 471 · cited 12×
“We show that BMP signaling has an antagonistic effect on Gdf11/Acvr2b signaling in vertebral patterning.”
BackgroundInfluentialRouault, J.-P., Falette, N., Guéhenneux, F., Guillot, C., Rimokh, R., Wang, Q., Berthet, C., Moyret-Lalle, C., Savatier, P., Pain, B., et al. (1996) · Nature Genetics · doi:10.1038/ng1296-482 · Cited by 434 · cited 2×
“Consistent with that finding, it was also shown that the Btg2 promoter contains functional p53-responsive elements (31) and that Btg2 is a primary p53 transcriptional target gene (14).”
BackgroundGuardavaccaro, D., Corrente, G., Covone, F., Micheli, L., D'Agnano, I., Starace, G., Caruso, M., & Tirone, F. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1797-1815.2000 · Cited by 230
Cited by
Zhang, S.-J., Steijaert, M. N., Lau, D., Schütz, G., Delucinge-Vivier, C., Descombes, P., & Bading, H. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.025 · Cited by 302
The mammalian anti‐proliferative BTG/Tob protein family
Winkler, G. S. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.21919 · Cited by 287
Tumor suppressors BTG1 and BTG2: Beyond growth control
Yuniati, L., Scheijen, B., van der Meer, L. T., & van Leeuwen, F. N. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27407 · Cited by 229
“As Btg2 was also found to be a positive regulator of the bone morphogenetic protein (BMP) signaling pathway, this vertebral transformation in Btg2‐null mice was proposed to be a consequence of attenuated BMP signaling (S. Park et al., 2004).”
BackgroundTaylor, S., Hu, R., Pacheco, E., Locher, K., Pyrah, I., Ominsky, M. S., & Boyce, R. W. (2018) · Bone Reports · doi:10.1016/j.bonr.2018.03.002 · Cited by 25
“The observed changes in expression of Btg2 may relate more to its reported function as an enhancer of BMP signaling (Park et al., 2004).”
BackgroundMicheli, L., Ceccarelli, M., Gioia, R., D’Andrea, G., Farioli-Vecchioli, S., Costanzi, M., Saraulli, D., Cestari, V., & Tirone, F. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00186 · Cited by 19
Metadata
- Authors
- Park, S., Lee, Y. J., Lee, H.-J., Seki, T., Hong, K.-H., Park, J., Beppu, H., Lim, I. K., Yoon, J.-W., Li, E., Kim, S.-J., & Oh, S. P.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2004-12-01
- Volume
- 24
- Issue
- 23
- Pages
- 10256-10262
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2128377517
- Cited by
- 69
- References
- 4
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.